Inpatient Proposed Rule Maps Higher Payment Rates For Complex Stenting
This article was originally published in The Pink Sheet Daily
Coronary stent diagnosis-related groups with secondary diagnoses would receive higher payments under the fiscal year 2006 inpatient prospective payment system proposed rule, the Centers for Medicare & Medicaid Services announces.
You may also be interested in...
The federal government is on the verge of ensuring that 90% of Medicare-eligible people receive prescription drug coverage, HHS Secretary Leavitt said.
HHS Office of Inspector General will decide whether GlaxoSmithKline can donate medicines to Part D-enrolled patients.
BioScrip will be the only provider of Medicare Part B-covered drugs through the competitive acquisition program for three years.